Cover
Cover - shares | 6 Months Ended | |
Jul. 31, 2024 | Aug. 21, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jul. 31, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-38056 | |
Entity Registrant Name | YEXT, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 20-8059722 | |
Entity Address, Address Line One | 61 Ninth Avenue | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10011 | |
City Area Code | 212 | |
Local Phone Number | 994-3900 | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | YEXT | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Reporting Company | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 127,920,766 | |
Entity Central Index Key | 0001614178 | |
Current Fiscal Year End Date | --01-31 | |
Document Fiscal Year Focus | 2025 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jul. 31, 2024 | Jan. 31, 2024 |
Current assets: | ||
Cash and cash equivalents | $ 234,823 | $ 210,184 |
Accounts receivable, net of allowances of $926 and $1,013, respectively | 45,870 | 108,198 |
Prepaid expenses and other current assets | 18,312 | 14,849 |
Costs to obtain revenue contracts, current | 23,048 | 26,680 |
Total current assets | 322,053 | 359,911 |
Property and equipment, net | 44,037 | 48,542 |
Operating lease right-of-use assets | 71,872 | 75,989 |
Costs to obtain revenue contracts, non-current | 12,793 | 16,710 |
Goodwill | 4,478 | 4,478 |
Intangible assets, net | 156 | 168 |
Other long term assets | 2,815 | 3,012 |
Total assets | 458,204 | 508,810 |
Current liabilities: | ||
Accounts payable, accrued expenses and other current liabilities | 33,740 | 38,766 |
Unearned revenue, current | 156,194 | 212,210 |
Operating lease liabilities, current | 17,574 | 16,798 |
Total current liabilities | 207,508 | 267,774 |
Operating lease liabilities, non-current | 83,201 | 89,562 |
Other long term liabilities | 4,692 | 4,300 |
Total liabilities | 295,401 | 361,636 |
Commitments and contingencies (Note 11) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value per share; 50,000,000 shares authorized at July 31, 2024 and January 31, 2024; zero shares issued and outstanding at July 31, 2024 and January 31, 2024 | 0 | 0 |
Common stock, $0.001 par value per share; 500,000,000 shares authorized at July 31, 2024 and January 31, 2024; 150,518,464 and 148,197,347 shares issued at July 31, 2024 and January 31, 2024, respectively; 127,144,940 and 124,867,093 shares outstanding at July 31, 2024 and January 31, 2024, respectively | 150 | 148 |
Additional paid-in capital | 966,550 | 942,622 |
Accumulated other comprehensive loss | (4,359) | (4,183) |
Accumulated deficit | (687,046) | (679,172) |
Treasury stock, at cost | (112,492) | (112,241) |
Total stockholders’ equity | 162,803 | 147,174 |
Total liabilities and stockholders’ equity | $ 458,204 | $ 508,810 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Jul. 31, 2024 | Jan. 31, 2024 |
Statement of Financial Position [Abstract] | ||
Allowance for doubtful accounts | $ 926 | $ 1,013 |
Preferred stock par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock shares authorized (in shares) | 50,000,000 | 50,000,000 |
Preferred stock shares issued (in shares) | 0 | 0 |
Preferred stock shares outstanding (in shares) | 0 | 0 |
Common stock par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock shares issued (in shares) | 150,518,464 | 148,197,347 |
Common stock shares outstanding (in shares) | 127,144,940 | 124,867,093 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Income Statement [Abstract] | ||||
Revenue | $ 97,887 | $ 102,598 | $ 193,877 | $ 202,051 |
Cost of revenue | 22,293 | 22,393 | 43,839 | 43,743 |
Gross profit | 75,594 | 80,205 | 150,038 | 158,308 |
Operating expenses: | ||||
Sales and marketing | 41,957 | 47,591 | 85,211 | 91,587 |
Research and development | 18,580 | 18,890 | 35,639 | 35,643 |
General and administrative | 22,623 | 17,955 | 42,180 | 36,541 |
Total operating expenses | 83,160 | 84,436 | 163,030 | 163,771 |
Loss from operations | (7,566) | (4,231) | (12,992) | (5,463) |
Interest income | 2,395 | 1,840 | 4,755 | 3,374 |
Interest expense | (124) | (88) | (516) | (161) |
Other expense, net | (204) | (297) | (342) | (617) |
Loss from operations before income taxes | (5,499) | (2,776) | (9,095) | (2,867) |
Benefit from (provision for) income taxes | 1,442 | (661) | 1,221 | (982) |
Net loss | $ (4,057) | $ (3,437) | $ (7,874) | $ (3,849) |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.06) | $ (0.03) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.06) | $ (0.03) |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 126,535,481 | 124,358,526 | 125,967,631 | 123,821,653 |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 126,535,481 | 124,358,526 | 125,967,631 | 123,821,653 |
Other comprehensive (loss) income: | ||||
Foreign currency translation adjustment | $ 237 | $ (196) | $ (180) | $ 154 |
Unrealized gain (loss) on marketable securities, net | 12 | (8) | 4 | (12) |
Total comprehensive loss | $ (3,808) | $ (3,641) | $ (8,050) | $ (3,707) |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Treasury Stock |
Beginning of period (in shares) at Jan. 31, 2023 | 122,335,000 | |||||
Beginning of period at Jan. 31, 2023 | $ 128,023 | $ 142 | $ 897,368 | $ (3,617) | $ (676,542) | $ (89,328) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options (in shares) | 1,514,000 | |||||
Exercise of stock options | 8,583 | $ 1 | 8,582 | |||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares) | 1,464,000 | |||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes | (7,752) | $ 2 | (7,754) | |||
Issuance of restricted stock (in shares) | 75,000 | |||||
Issuance of common stock under employee stock purchase plan (in shares) | 492,000 | |||||
Issuance of common stock under employee stock purchase plan | 2,120 | $ 1 | 2,119 | |||
Stock-based compensation | 22,779 | 22,779 | ||||
Repurchase of common stock (in shares) | (1,226,000) | |||||
Repurchase of common stock | (11,025) | (11,025) | ||||
Other comprehensive income (loss) | 142 | 142 | ||||
Net loss | (3,849) | (3,849) | ||||
End of period (in shares) at Jul. 31, 2023 | 124,654,000 | |||||
End of period at Jul. 31, 2023 | 139,021 | $ 146 | 923,094 | (3,475) | (680,391) | (100,353) |
Beginning of period (in shares) at Apr. 30, 2023 | 124,214,000 | |||||
Beginning of period at Apr. 30, 2023 | 140,587 | $ 145 | 914,608 | (3,271) | (676,954) | (93,941) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options (in shares) | 258,000 | |||||
Exercise of stock options | 1,339 | 1,339 | ||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares) | 782,000 | |||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes | (4,512) | $ 1 | (4,513) | |||
Issuance of restricted stock (in shares) | 62,000 | |||||
Stock-based compensation | 11,660 | 11,660 | ||||
Repurchase of common stock (in shares) | (662,000) | |||||
Repurchase of common stock | (6,412) | (6,412) | ||||
Other comprehensive income (loss) | (204) | (204) | ||||
Net loss | (3,437) | (3,437) | ||||
End of period (in shares) at Jul. 31, 2023 | 124,654,000 | |||||
End of period at Jul. 31, 2023 | $ 139,021 | $ 146 | 923,094 | (3,475) | (680,391) | (100,353) |
Beginning of period (in shares) at Jan. 31, 2024 | 124,867,093 | 124,867,000 | ||||
Beginning of period at Jan. 31, 2024 | $ 147,174 | $ 148 | 942,622 | (4,183) | (679,172) | (112,241) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options (in shares) | 258,606 | 259,000 | ||||
Exercise of stock options | $ 791 | 791 | ||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares) | 1,411,000 | |||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes | (3,786) | $ 2 | (3,788) | |||
Issuance of restricted stock (in shares) | 138,000 | |||||
Issuance of common stock under employee stock purchase plan (in shares) | 513,000 | |||||
Issuance of common stock under employee stock purchase plan | 2,351 | 2,351 | ||||
Stock-based compensation | 24,574 | 24,574 | ||||
Repurchase of common stock (in shares) | (43,000) | |||||
Repurchase of common stock | (251) | (251) | ||||
Other comprehensive income (loss) | (176) | (176) | ||||
Net loss | $ (7,874) | (7,874) | ||||
End of period (in shares) at Jul. 31, 2024 | 127,144,940 | 127,145,000 | ||||
End of period at Jul. 31, 2024 | $ 162,803 | $ 150 | 966,550 | (4,359) | (687,046) | (112,492) |
Beginning of period (in shares) at Apr. 30, 2024 | 126,129,000 | |||||
Beginning of period at Apr. 30, 2024 | 155,674 | $ 149 | 955,363 | (4,608) | (682,989) | (112,241) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Exercise of stock options (in shares) | 166,000 | |||||
Exercise of stock options | 508 | 508 | ||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes (in shares) | 775,000 | |||||
Vested restricted stock units converted to common shares, net of shares withheld for employee taxes | (1,740) | $ 1 | (1,741) | |||
Issuance of restricted stock (in shares) | 118,000 | |||||
Stock-based compensation | 12,420 | 12,420 | ||||
Repurchase of common stock (in shares) | (43,000) | |||||
Repurchase of common stock | (251) | (251) | ||||
Other comprehensive income (loss) | 249 | 249 | ||||
Net loss | $ (4,057) | (4,057) | ||||
End of period (in shares) at Jul. 31, 2024 | 127,144,940 | 127,145,000 | ||||
End of period at Jul. 31, 2024 | $ 162,803 | $ 150 | $ 966,550 | $ (4,359) | $ (687,046) | $ (112,492) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Operating activities: | ||
Net loss | $ (7,874) | $ (3,849) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization expense | 5,814 | 9,089 |
Bad debt expense | 363 | 602 |
Stock-based compensation expense | 24,398 | 22,577 |
Amortization of operating lease right-of-use assets | 4,265 | 4,611 |
Other, net | 481 | 184 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 62,021 | 54,943 |
Prepaid expenses and other current assets | (3,231) | (538) |
Costs to obtain revenue contracts | 7,619 | 6,554 |
Other long term assets | 215 | 726 |
Accounts payable, accrued expenses and other current liabilities | (4,649) | (14,158) |
Unearned revenue | (56,370) | (55,324) |
Operating lease liabilities | (5,742) | (5,848) |
Other long term liabilities | 350 | 141 |
Net cash provided by operating activities | 27,660 | 19,710 |
Investing activities: | ||
Capital expenditures | (1,192) | (1,567) |
Net cash used in investing activities | (1,192) | (1,567) |
Financing activities: | ||
Proceeds from exercise of stock options | 791 | 8,610 |
Repurchase of common stock | (201) | (10,996) |
Payments for taxes related to net share settlement of stock-based compensation awards | (3,781) | (7,750) |
Payments of deferred financing costs | (659) | (301) |
Proceeds, net from employee stock purchase plan withholdings | 1,842 | 2,176 |
Net cash used in financing activities | (2,008) | (8,261) |
Effect of exchange rate changes on cash and cash equivalents | 179 | 431 |
Net increase in cash and cash equivalents | 24,639 | 10,313 |
Cash and cash equivalents at beginning of period | 210,184 | 190,214 |
Cash and cash equivalents at end of period | $ 234,823 | $ 200,527 |
Organization and Description of
Organization and Description of Business | 6 Months Ended |
Jul. 31, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Description of Business | Organization and Description of Business Description of Business Yext, Inc. ("Yext" or the "Company") empowers businesses to manage their knowledge so they can deliver relevant, actionable answers to consumer questions as well as consistent, accurate and engaging experiences to customers throughout the digital ecosystem. The Company's digital presence platform (also known as the Answers Platform) lets businesses structure and organize information about their brands in the Company's knowledge graph, Yext Content (also known as the Knowledge Graph), which is then delivered across first- and third-party websites and applications through its network of over 200 service and application providers, which the Company refers to as its Publisher Network. The Company's platform powers all of the Company's key products, including Listings, Reviews, Pages, and Search, each with robust analytics capabilities for businesses to easily track performance across customer experiences. Fiscal Year The Company's fiscal year ends on January 31 st . References to fiscal 2025, for example, are to the fiscal year ending January 31, 2025. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jul. 31, 2024 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2024, filed with the SEC on March 13, 2024 (the "Form 10-K"). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2024, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the six months ended July 31, 2024 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending January 31, 2025, or any other period. There have been no material changes to the Company's significant accounting policies as described in the Form 10-K. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of those financial statements and the reported amounts of revenue and expense during the reporting period. These estimates include, but are not limited to, the standalone selling prices of performance obligations, the incremental borrowing rate associated with lease liabilities, the useful life of capitalized costs to obtain revenue contracts, income taxes, and the valuation and assumptions underlying stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the financial position and results of operations. Segment Information The Company is the provider of the platform and operates as one operating segment. An operating segment is defined as a component of an enterprise for which separate financial information is evaluated regularly by the chief operating decision makers ("CODM"). The Company defines its CODM as its executive officers, and their role is to make decisions about allocating resources and assessing performance. The Company's business operates as one operating segment as all of the Company's offerings operate on the Company's platform and are deployed in an identical way, with its CODM evaluating the Company's financial information, resources and performance of these resources on a consolidated basis. Since the Company operates as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements. Recent Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for the Company's annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company’s annual periods beginning in fiscal 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the impact of ASU 2023-09. |
Revenue
Revenue | 6 Months Ended |
Jul. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Performance Obligations The Company has identified that it has two distinct performance obligations: subscription and associated support to the Company's platform and professional services. The Company's revenue is predominately related to its subscription and associated support to the Company's platform. Professional services revenue accounted for approximately 7% and 8% of the Company's total revenue for the six months ended July 31, 2024 and 2023, respectively. Geographic Region The Company disaggregates its revenue from contracts with customers by geographic region, as it believes this best depicts how the nature, amount, timing, and uncertainty of its revenues and cash flows are affected by economic factors. Revenue by geographic region is determined based on the region of the Company's contracting entity, which may be different than the region of its customers. The following table presents the Company's revenue by geographic region: Three months ended July 31, Six months ended July 31, (in thousands) 2024 2023 2024 2023 North America $ 76,823 $ 80,819 $ 152,180 $ 159,319 International 21,064 21,779 41,697 42,732 Total revenue $ 97,887 $ 102,598 $ 193,877 $ 202,051 North America revenue is attributable to the United States. International revenue is predominantly attributable to European countries, but also includes Japan. The Company's revenue attributable to the United States represented 78% of total revenue, revenue attributable to the United Kingdom, which serves as the Company's main contracting entity for Europe, represented 20% of total revenue, and no other individual country represented more than 10% of total revenue for the six months ended July 31, 2024. The Company's revenue attributable to the United States represented 79% of total revenue, revenue attributable to the United Kingdom, which serves as the Company's main contracting entity for Europe, represented 20% of total revenue, and no other individual country represented more than 10% of total revenue for the six months ended July 31, 2023. Contract Assets The Company records a contract asset when revenue is recognized prior to being billed. Contract assets were $1.0 million as of July 31, 2024 and were not significant as of January 31, 2024. Contract assets are included in prepaid expenses and other current assets on the condensed consolidated balance sheet. Contract Liabilities A contract liability is an obligation to transfer goods or services for which consideration has been received or is due to a customer. The Company's contract liabilities consist primarily of unearned revenue and, to a lesser extent, customer deposits. As of July 31, 2024, unearned revenue, current was $156.2 million, while unearned revenue, non-current, which is included within other long term liabilities on the Company's condensed consolidated balance sheet, was $0.8 million. Revenue recognized of $144.2 million during the six months ended July 31, 2024 was included in unearned revenue at the beginning of the period. Customer deposits represent payments received in advance in instances where a revenue contract is cancelable in nature, and therefore the Company does not have an unconditional obligation to transfer control to a customer. As of July 31, 2024 and January 31, 2024, customer deposits of $1.0 million and $0.2 million are included in accounts payable, accrued expenses and other current liabilities on the Company's condensed consolidated balance sheet, respectively. Remaining Performance Obligations The transaction price allocated to remaining performance obligations represents amounts under non-cancelable contracts expected to be recognized as revenue in future periods, and may be influenced by several factors, including seasonality, the timing of renewals, and contract terms. As of July 31, 2024, the Company had $396.5 million of remaining performance obligations, of which $349.4 million is expected to be recognized as revenue over the next twenty-four months, with the remaining balance expected to be recognized thereafter. As of January 31, 2024, the Company had $465.1 million of remaining performance obligations. |
Investments in Marketable Secur
Investments in Marketable Securities | 6 Months Ended |
Jul. 31, 2024 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments in Marketable Securities | Investments in Marketable Securities The following tables summarize the Company's investments in marketable securities: July 31, 2024 (in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair Value Money market funds $ 415 $ — $ — $ 415 U.S. treasury securities 44,150 — (2) 44,148 Total marketable securities $ 44,565 $ — $ (2) $ 44,563 January 31, 2024 (in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair Value Money market funds $ 63,966 $ — $ — $ 63,966 U.S. treasury securities 82,642 — (7) 82,635 Total marketable securities $ 146,608 $ — $ (7) $ 146,601 As of July 31, 2024 and January 31, 2024, the Company's marketable securities have a maturity of 90 days or less and are classified as cash and cash equivalents. During the six months ended July 31, 2024 and 2023, the Company had no material reclassification adjustments from accumulated other comprehensive loss to net loss. The Company classifies interest income on investments in marketable securities, amortization of premiums and discounts, and realized gains and losses on securities available for sale within interest income in the condensed consolidated statements of operations and comprehensive loss. The Company regularly reviews its debt securities and monitors the surrounding economic conditions to assess the risk of expected credit losses. As of July 31, 2024 and January 31, 2024, the unrealized losses and the related risk of expected credit losses were not significant. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 6 Months Ended |
Jul. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Subsequent changes in fair value of these financial assets and liabilities are recognized in earnings or other comprehensive (loss) income when they occur. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurement or assumptions that market participants would use in pricing the assets or liabilities, such as inherent risk, transfer restrictions, and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 inputs are based on quoted prices in active markets for identical assets or liabilities. Level 2 inputs are based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 inputs are based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management's estimates of assumptions that market participants would use in pricing the asset or liability. The Company's assets measured at fair value on a recurring basis, by level, within the fair value hierarchy are as follows: July 31, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 415 $ — $ — $ 415 U.S. treasury securities — 44,148 — 44,148 Included in cash and cash equivalents $ 415 $ 44,148 $ — $ 44,563 January 31, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 63,966 $ — $ — $ 63,966 U.S. treasury securities — 82,635 — 82,635 Included in cash and cash equivalents $ 63,966 $ 82,635 $ — $ 146,601 The Company’s cash equivalents and marketable securities for the periods presented were valued using quoted market prices or alternative pricing sources and models utilizing observable market inputs and were classified as Level 1 or Level 2, accordingly. |
Property and Equipment, Net
Property and Equipment, Net | 6 Months Ended |
Jul. 31, 2024 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and Equipment, Net Property and equipment are recorded at cost and depreciated or amortized on a straight-line basis over their estimated useful lives. Property and equipment, net consisted of the following: (in thousands) July 31, 2024 January 31, 2024 Computer software $ 23,204 $ 22,500 Office equipment 22,967 22,674 Furniture and fixtures 7,949 7,930 Leasehold improvements 60,079 59,927 Construction in progress 9 249 Software in progress 744 370 Total property and equipment, gross 114,952 113,650 Less: accumulated depreciation (70,915) (65,108) Total property and equipment, net $ 44,037 $ 48,542 As of July 31, 2024 and January 31, 2024, the Comp |
Accounts Payable, Accrued Expen
Accounts Payable, Accrued Expenses and Other Current Liabilities | 6 Months Ended |
Jul. 31, 2024 | |
Payables and Accruals [Abstract] | |
Accounts Payable, Accrued Expenses and Other Current Liabilities | Accounts Payable, Accrued Expenses and Other Current Liabilities Accounts payable, accrued expenses and other current liabilities consisted of the following: (in thousands) July 31, 2024 January 31, 2024 Accounts payable $ 5,673 $ 7,430 Accrued employee compensation 12,086 15,961 Accrued Publisher Network fees 1,956 1,839 Accrued professional services and associated costs 4,456 2,307 Accrued employee stock purchase plan withholdings liability 1,449 1,958 Other current liabilities 8,120 9,271 Total accounts payable, accrued expenses and other current liabilities $ 33,740 $ 38,766 |
Stock-Based Compensation
Stock-Based Compensation | 6 Months Ended |
Jul. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation Stock-Based Compensation Expense Stock-based compensation represents the cost related to stock-based awards granted in lieu of monetary payment. The Company measures stock-based compensation associated with stock-based awards issued to employees at the grant date, based on the estimated fair value of the award, and recognizes expense, net of estimated forfeitures, over the requisite service period of the applicable award generally using the straight-line method or accelerated attribution method. The following table summarizes the Company's stock-based compensation expense for the periods presented: Three months ended July 31, Six months ended July 31, (in thousands) 2024 2023 2024 2023 Cost of revenue $ 698 $ 768 $ 1,386 $ 1,412 Sales and marketing 3,155 4,067 5,906 7,886 Research and development 2,607 2,768 5,390 5,563 General and administrative 5,873 3,962 11,716 7,716 Total stock-based compensation expense $ 12,333 $ 11,565 $ 24,398 $ 22,577 Stock Options The following table summarizes the activity related to the Company's stock options: Outstanding Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value Balance, January 31, 2024 2,021,494 $ 6.26 2.20 $ 989 Granted — $ — Exercised (258,606) $ 3.06 Forfeited or canceled (9,709) $ 10.35 Balance, July 31, 2024 1,753,179 $ 6.71 1.82 $ 227 Vested and expected to vest 1,753,179 $ 6.71 1.82 $ 227 Exercisable, July 31, 2024 1,753,179 $ 6.71 1.82 $ 227 Restricted Stock and Restricted Stock Units The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2024 9,790,748 $ 7.54 Granted 4,650,552 $ 5.58 Vested and converted to shares (2,183,455) $ 8.96 Forfeited or canceled (1,424,528) $ 7.12 Balance, July 31, 2024 10,833,317 $ 6.47 Performance-Based Restricted Stock Units The following table summarizes the activity related to the Company’s performance-based restricted stock units ("PSUs"): Number of PSUs Weighted-Average Grant Date Fair Value Balance, January 31, 2024 3,555,000 $ 5.98 Granted — $ — Vested — $ — Forfeited or canceled (25,000) $ 5.05 Balance, July 31, 2024 3,530,000 $ 5.98 |
Debt
Debt | 6 Months Ended |
Jul. 31, 2024 | |
Debt Disclosure [Abstract] | |
Debt | Debt On March 11, 2020, the Company entered into a credit agreement (the “Credit Agreement”) with Silicon Valley Bank (“SVB”). In January 2021, the Company amended the Credit Agreement which modified the conditions pursuant to which subsidiaries are required to become guarantors. On December 22, 2022, the Company entered into a second amendment (“Amendment No. 2”) to the Credit Agreement, dated March 11, 2020, and on July 26, 2024, the Company entered into a third amendment ("Amendment No. 3") to the Credit Agreement, collectively referred to as the Credit Facility. No significant debt issuance costs were incurred in association with Amendment No.2 and Amendment No.3. Amendment No. 2 amended the Credit Facility to, among other things (i) extend the maturity date of the Credit Facility to December 22, 2025, (ii) amend the interest rate provisions to replace LIBOR with SOFR as the interest rate benchmark, and (iii) amend the recurring revenue growth rate financial covenant. Amendment No. 3 amended the Credit Facility to, among other things (i) amend the interest rate applicable to loans under the Credit Facility, and (ii) replace the consolidated quick ratio and recurring revenue growth rate financial covenants with consolidated total leverage ratio and minimum liquidity financial covenants. The Credit Facility provides for a senior secured revolving loan facility of up to $50.0 million that matures on December 22, 2025, with the right subject to certain conditions to add an incremental revolving loan facility of up to $50.0 million in the aggregate. The revolving loan facility provides for borrowings up to the amount of the facility with sub-limits of up to (i) $30.0 million to be available for the issuance of letters of credit and (ii) $10.0 million to be available for swingline loans. As amended, the revolving loans bear interest, at the Company’s election, at an annual rate based on SOFR or a base rate. Loans based on SOFR shall bear interest at a rate between SOFR plus 1.75% and SOFR plus 2.25%, depending on the Company’s consolidated total leverage ratio and subject to a SOFR floor of 1.00%. Loans based on the base rate shall bear interest at a rate between the base rate minus 1.25% and the base rate minus 0.75%, depending on the Company’s consolidated total leverage ratio. The Company is also obligated to pay a commitment fee on the unused portion of the facility at a rate of 0.25% per annum. The obligations under the Credit Facility are secured by a lien on substantially all of the Company's tangible and intangible property and by a pledge of all of the Company's equity interests of material direct and indirect domestic subsidiaries and 66% of each class of capital stock of any material first-tier foreign subsidiaries, subject to limited exceptions. The Credit Facility contains customary affirmative and negative covenants and restrictions, as well as financial covenants that require us to maintain minimum liquidity of $35.0 million at all times and a consolidated total leverage ratio of no greater than 3.00 to 1.00, tested on a quarterly basis. |
Income Taxes
Income Taxes | 6 Months Ended |
Jul. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company calculates its year-to-date benefit from (provision for) income taxes by applying the estimated annual effective tax rate ("AETR") to year-to-date income or loss from operations before income taxes and adjusts for discrete tax items recorded in the period. During the three and six months ended July 31, 2024, the Company recorded a benefit from income taxes of $1.4 million and $1.2 million, respectively. During the three and six months ended July 31, 2023, the Company recorded a (provision for) income taxes of $(0.7) million and $(1.0) million, respectively. The Company's effective tax rate generally differs from the U.S. federal statutory tax rate primarily due to full valuation allowances related to the Company's net deferred tax assets in the U.S. and certain foreign jurisdictions, U.S. state income taxes, and foreign rate differential on profitable jurisdictions. The Company regularly evaluates the realizability of its deferred tax assets and establishes a valuation allowance on a jurisdictional basis if it is more likely than not that some or all the deferred tax assets will not be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, loss carryback, and tax-planning strategies. Generally, more weight is given to objectively verifiable evidence, such as the cumulative loss in recent years, as a significant piece of negative evidence to overcome. To the extent sufficient positive evidence becomes available, a portion of the valuation allowance against certain net deferred tax assets could be released in the future and would result in a non-cash income tax benefit in the period of release. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jul. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Contractual Obligations The Company is obligated to make payments under certain non-cancelable contractual obligations in the normal course of business. The Company's contractual obligations primarily relate to its operating and short-term lease arrangements for office space. Its other contractual obligations include contracts with its Publisher Network application providers, which generally have a term of one year, although some have a term of several years, and its software vendors, among others. These obligations represent minimum contractual payments, or the Company's best estimate for variable elements based on historical payments. The Company's contractual obligations have various expiry dates between fiscal years 2025 and 2035. As of July 31, 2024, the Company's contractual obligations are as follows (in thousands): Fiscal year ending January 31: Leases Other 2025 (remainder of fiscal year) $ 8,562 $ 21,342 2026 19,274 15,675 2027 19,340 8,937 2028 19,437 4,525 2029 19,297 16 2030 and thereafter 36,473 94 Total $ 122,383 $ 50,589 Legal Proceedings The Company is and may be involved in various legal proceedings arising in the normal course of business. Although the results of litigation and claims cannot be predicted with certainty, currently, in the opinion of the Company, the likelihood of any material adverse impact on the Company's results of operations, cash flows or the Company's financial position for any such litigation or claims is deemed to be remote. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense costs, diversion of management resources and other factors. Warranties and Indemnifications The Company's platform is in some cases warranted to perform in a manner consistent with general industry standards that are reasonably applicable and materially in accordance with the Company's product specifications. The Company's arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third-party's intellectual property rights and/or if the Company breaches its contractual agreements with a customer or in instances of negligence, fraud or willful misconduct by the Company. To date, the Company has not incurred any material costs as a result of such obligations and has not accrued any significant liabilities related to such obligations in the accompanying condensed consolidated financial statements. The Company has also agreed to indemnify certain of its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person's service as a director or officer, including any action by the Company, arising out of that person's services as the Company's director or officer or that person's services provided to any other company or enterprise at the Company's request. The Company maintains director and officer insurance coverage that would generally enable the Company to recover a portion of future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. |
Net Loss Per Share Attributable
Net Loss Per Share Attributable to Common Stockholders | 6 Months Ended |
Jul. 31, 2024 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share Attributable to Common Stockholders | Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders: Three months ended July 31, Six months ended July 31, (in thousands, except share and per share data) 2024 2023 2024 2023 Numerator: Net loss attributable to common stockholders $ (4,057) $ (3,437) $ (7,874) $ (3,849) Denominator: Weighted-average common shares outstanding 126,535,481 124,358,526 125,967,631 123,821,653 Net loss per share attributable to common stockholders, basic and diluted $ (0.03) $ (0.03) $ (0.06) $ (0.03) Basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Unvested restricted stock, restricted stock units, and performance-based restricted stock units where the market conditions have not been met are excluded from the denominator of basic net loss per share. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares plus common equivalent shares for the period, including any dilutive effect from such shares. Since the Company was in a net loss position for all periods presented, net loss per share attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive. Anti-dilutive common equivalent shares were as follows: As of July 31, 2024 2023 Options to purchase common stock 1,753,179 3,079,658 Restricted stock and restricted stock units 10,833,317 11,167,766 Shares estimated to be purchased under ESPP 373,424 225,903 Performance-based restricted stock units (1) 3,530,000 2,280,000 Total anti-dilutive common equivalent shares 16,489,920 16,753,327 (1) An additional 1.3 million shares of common stock may be awarded for certain PSUs based on the Company's total shareholder return ("TSR") relative to the TSR of companies in the S&P Software and Services Select Index over specified performance periods. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jul. 31, 2024 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events Following approval by the Company's Board of Directors, on June 10, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) for the acquisition of Hearsay Social, Inc. (“Hearsay”). Pursuant to the Merger Agreement, Hearsay became a wholly owned subsidiary of Yext upon closing of the transaction on August 1, 2024. The Company acquired Hearsay for approximately $125 million in cash, as adjusted for customary adjustments set forth in the Merger Agreement, and the assumption of Hearsay employee equity awards. The Company also offered participation rights to key employees and former founders of Hearsay in a bonus pool of $20 million that can be settled in cash or the Company’s common stock and shall be subject to 100% vesting on the first anniversary of closing, generally subject to continued employment. In addition, subject to the terms of the Merger Agreement, the Company may also be required to pay additional contingent consideration of up to $75 million to Hearsay based on the achievement of certain milestones (the “Earnout Consideration”). The Earnout Consideration shall be payable based on achievement of certain annual recurring revenue targets. The targets shall be measured at the end of the first and second anniversaries of closing. The Earnout Consideration may be settled in cash or the Company’s common stock at the Company’s election. The Company is currently evaluating the impact of this acquisition on its consolidated financial statements. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Pay vs Performance Disclosure | ||||
Net loss | $ (4,057) | $ (3,437) | $ (7,874) | $ (3,849) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jul. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jul. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2024, filed with the SEC on March 13, 2024 (the "Form 10-K"). The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2024, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the six months ended July 31, 2024 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending January 31, 2025, or any other period. |
Use of Estimates | Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of those financial statements and the reported amounts of revenue and expense during the reporting period. These estimates include, but are not limited to, the standalone selling prices of performance obligations, the incremental borrowing rate associated with lease liabilities, the useful life of capitalized costs to obtain revenue contracts, income taxes, and the valuation and assumptions underlying stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could be material to the financial position and results of operations. |
Segment Information | Segment Information The Company is the provider of the platform and operates as one operating segment. An operating segment is defined as a component of an enterprise for which separate financial information is evaluated regularly by the chief operating decision makers ("CODM"). The Company defines its CODM as its executive officers, and their role is to make decisions about allocating resources and assessing performance. The Company's business operates as one operating segment as all of the Company's offerings operate on the Company's platform and are deployed in an identical way, with its CODM evaluating the Company's financial information, resources and performance of these resources on a consolidated basis. Since the Company operates as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for the Company's annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. Early adoption is permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company’s annual periods beginning in fiscal 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the impact of ASU 2023-09. |
Revenue (Tables)
Revenue (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following table presents the Company's revenue by geographic region: Three months ended July 31, Six months ended July 31, (in thousands) 2024 2023 2024 2023 North America $ 76,823 $ 80,819 $ 152,180 $ 159,319 International 21,064 21,779 41,697 42,732 Total revenue $ 97,887 $ 102,598 $ 193,877 $ 202,051 |
Investments in Marketable Sec_2
Investments in Marketable Securities (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Marketable Securities | The following tables summarize the Company's investments in marketable securities: July 31, 2024 (in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair Value Money market funds $ 415 $ — $ — $ 415 U.S. treasury securities 44,150 — (2) 44,148 Total marketable securities $ 44,565 $ — $ (2) $ 44,563 January 31, 2024 (in thousands) Amortized Cost Unrealized Gains Unrealized Losses Fair Value Money market funds $ 63,966 $ — $ — $ 63,966 U.S. treasury securities 82,642 — (7) 82,635 Total marketable securities $ 146,608 $ — $ (7) $ 146,601 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets Measured at Fair Value | The Company's assets measured at fair value on a recurring basis, by level, within the fair value hierarchy are as follows: July 31, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 415 $ — $ — $ 415 U.S. treasury securities — 44,148 — 44,148 Included in cash and cash equivalents $ 415 $ 44,148 $ — $ 44,563 January 31, 2024 (in thousands) Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 63,966 $ — $ — $ 63,966 U.S. treasury securities — 82,635 — 82,635 Included in cash and cash equivalents $ 63,966 $ 82,635 $ — $ 146,601 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment, Net | Property and equipment, net consisted of the following: (in thousands) July 31, 2024 January 31, 2024 Computer software $ 23,204 $ 22,500 Office equipment 22,967 22,674 Furniture and fixtures 7,949 7,930 Leasehold improvements 60,079 59,927 Construction in progress 9 249 Software in progress 744 370 Total property and equipment, gross 114,952 113,650 Less: accumulated depreciation (70,915) (65,108) Total property and equipment, net $ 44,037 $ 48,542 |
Accounts Payable, Accrued Exp_2
Accounts Payable, Accrued Expenses and Other Current Liabilities (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Payables and Accruals [Abstract] | |
Schedule of Accounts Payable, Accrued Expenses and Other Current Liabilities | Accounts payable, accrued expenses and other current liabilities consisted of the following: (in thousands) July 31, 2024 January 31, 2024 Accounts payable $ 5,673 $ 7,430 Accrued employee compensation 12,086 15,961 Accrued Publisher Network fees 1,956 1,839 Accrued professional services and associated costs 4,456 2,307 Accrued employee stock purchase plan withholdings liability 1,449 1,958 Other current liabilities 8,120 9,271 Total accounts payable, accrued expenses and other current liabilities $ 33,740 $ 38,766 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Share-Based Compensation Expense | The following table summarizes the Company's stock-based compensation expense for the periods presented: Three months ended July 31, Six months ended July 31, (in thousands) 2024 2023 2024 2023 Cost of revenue $ 698 $ 768 $ 1,386 $ 1,412 Sales and marketing 3,155 4,067 5,906 7,886 Research and development 2,607 2,768 5,390 5,563 General and administrative 5,873 3,962 11,716 7,716 Total stock-based compensation expense $ 12,333 $ 11,565 $ 24,398 $ 22,577 |
Schedule of Stock Options Activity | The following table summarizes the activity related to the Company's stock options: Outstanding Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in years) Aggregate Intrinsic Value Balance, January 31, 2024 2,021,494 $ 6.26 2.20 $ 989 Granted — $ — Exercised (258,606) $ 3.06 Forfeited or canceled (9,709) $ 10.35 Balance, July 31, 2024 1,753,179 $ 6.71 1.82 $ 227 Vested and expected to vest 1,753,179 $ 6.71 1.82 $ 227 Exercisable, July 31, 2024 1,753,179 $ 6.71 1.82 $ 227 |
Schedule of Restricted Stock and Restricted Stock Units | The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2024 9,790,748 $ 7.54 Granted 4,650,552 $ 5.58 Vested and converted to shares (2,183,455) $ 8.96 Forfeited or canceled (1,424,528) $ 7.12 Balance, July 31, 2024 10,833,317 $ 6.47 |
Schedule of Performance-Based Restricted Stock Units | The following table summarizes the activity related to the Company’s performance-based restricted stock units ("PSUs"): Number of PSUs Weighted-Average Grant Date Fair Value Balance, January 31, 2024 3,555,000 $ 5.98 Granted — $ — Vested — $ — Forfeited or canceled (25,000) $ 5.05 Balance, July 31, 2024 3,530,000 $ 5.98 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Future Minimum Contractual Obligation Payments | As of July 31, 2024, the Company's contractual obligations are as follows (in thousands): Fiscal year ending January 31: Leases Other 2025 (remainder of fiscal year) $ 8,562 $ 21,342 2026 19,274 15,675 2027 19,340 8,937 2028 19,437 4,525 2029 19,297 16 2030 and thereafter 36,473 94 Total $ 122,383 $ 50,589 |
Net Loss Per Share Attributab_2
Net Loss Per Share Attributable to Common Stockholders (Tables) | 6 Months Ended |
Jul. 31, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders: Three months ended July 31, Six months ended July 31, (in thousands, except share and per share data) 2024 2023 2024 2023 Numerator: Net loss attributable to common stockholders $ (4,057) $ (3,437) $ (7,874) $ (3,849) Denominator: Weighted-average common shares outstanding 126,535,481 124,358,526 125,967,631 123,821,653 Net loss per share attributable to common stockholders, basic and diluted $ (0.03) $ (0.03) $ (0.06) $ (0.03) |
Schedule of Antidilutive Securities | Anti-dilutive common equivalent shares were as follows: As of July 31, 2024 2023 Options to purchase common stock 1,753,179 3,079,658 Restricted stock and restricted stock units 10,833,317 11,167,766 Shares estimated to be purchased under ESPP 373,424 225,903 Performance-based restricted stock units (1) 3,530,000 2,280,000 Total anti-dilutive common equivalent shares 16,489,920 16,753,327 (1) An additional 1.3 million shares of common stock may be awarded for certain PSUs based on the Company's total shareholder return ("TSR") relative to the TSR of companies in the S&P Software and Services Select Index over specified performance periods. |
Organization and Description _2
Organization and Description of Business (Details) | Jul. 31, 2024 provider |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of service and application providers | 200 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) | 6 Months Ended |
Jul. 31, 2024 operating_segment | |
Accounting Policies [Abstract] | |
Number of operating segments | 1 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) $ in Thousands | 6 Months Ended | ||
Jul. 31, 2024 USD ($) performance_obligation | Jul. 31, 2023 | Jan. 31, 2024 USD ($) | |
Revenue from External Customer [Line Items] | |||
Number of performance obligations | performance_obligation | 2 | ||
Customer contract assets | $ 1,000 | ||
Unearned revenue, current | 156,194 | $ 212,210 | |
Unearned revenue, noncurrent | 800 | ||
Unearned revenue, revenue recognized | 144,200 | ||
Customer deposits | $ 1,000 | $ 200 | |
Sales Revenue, Net | Product Concentration Risk | Professional Services | |||
Revenue from External Customer [Line Items] | |||
Concentration risk, percentage | 7% | 8% | |
Sales Revenue, Net | Geographic Concentration Risk | UNITED STATES | |||
Revenue from External Customer [Line Items] | |||
Concentration risk, percentage | 78% | 79% | |
Sales Revenue, Net | Geographic Concentration Risk | UNITED KINGDOM | |||
Revenue from External Customer [Line Items] | |||
Concentration risk, percentage | 20% | 20% |
Revenue -Schedule of Disaggrega
Revenue -Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 97,887 | $ 102,598 | $ 193,877 | $ 202,051 |
North America | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 76,823 | 80,819 | 152,180 | 159,319 |
International | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 21,064 | $ 21,779 | $ 41,697 | $ 42,732 |
Revenue - Remaining Performance
Revenue - Remaining Performance Obligations (Details) - USD ($) $ in Millions | Jul. 31, 2024 | Jan. 31, 2024 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, amount | $ 396.5 | $ 465.1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-08-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, amount | $ 349.4 | |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 24 months | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-08-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Revenue, remaining performance obligation, expected timing of satisfaction, period |
Investments in Marketable Sec_3
Investments in Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands | Jul. 31, 2024 | Jan. 31, 2024 |
Gain (Loss) on Securities [Line Items] | ||
Amortized Cost | $ 44,565 | $ 146,608 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (2) | (7) |
Fair Value | 44,563 | 146,601 |
Money market funds | ||
Gain (Loss) on Securities [Line Items] | ||
Amortized Cost | 415 | 63,966 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | 0 | 0 |
Fair Value | 415 | 63,966 |
U.S. treasury securities | ||
Gain (Loss) on Securities [Line Items] | ||
Amortized Cost | 44,150 | 82,642 |
Unrealized Gains | 0 | 0 |
Unrealized Losses | (2) | (7) |
Fair Value | $ 44,148 | $ 82,635 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - (Details) - Recurring - USD ($) $ in Thousands | Jul. 31, 2024 | Jan. 31, 2024 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 44,563 | $ 146,601 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 415 | 63,966 |
U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 44,148 | 82,635 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 415 | 63,966 |
Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 415 | 63,966 |
Level 1 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 44,148 | 82,635 |
Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 2 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 44,148 | 82,635 |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 3 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | 0 | 0 |
Level 3 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash equivalents | $ 0 | $ 0 |
Property and Equipment, Net (De
Property and Equipment, Net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | Jan. 31, 2024 | |
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | $ 114,952 | $ 114,952 | $ 113,650 | ||
Less: accumulated depreciation | (70,915) | (70,915) | (65,108) | ||
Total property and equipment, net | 44,037 | 44,037 | $ 48,542 | ||
Depreciation expense | 2,900 | $ 4,400 | $ 5,800 | $ 9,100 | |
Geographic Concentration Risk | UNITED STATES | Property, Plant and Equipment | |||||
Property, Plant and Equipment [Line Items] | |||||
Concentration risk, percentage | 91% | 90% | |||
Computer software | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | 23,204 | $ 23,204 | $ 22,500 | ||
Office equipment | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | 22,967 | 22,967 | 22,674 | ||
Furniture and fixtures | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | 7,949 | 7,949 | 7,930 | ||
Leasehold improvements | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | 60,079 | 60,079 | 59,927 | ||
Construction in progress | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | 9 | 9 | 249 | ||
Software in progress | |||||
Property, Plant and Equipment [Line Items] | |||||
Total property and equipment, gross | $ 744 | $ 744 | $ 370 |
Accounts Payable, Accrued Exp_3
Accounts Payable, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Jul. 31, 2024 | Jan. 31, 2024 |
Payables and Accruals [Abstract] | ||
Accounts payable | $ 5,673 | $ 7,430 |
Accrued employee compensation | 12,086 | 15,961 |
Accrued Publisher Network fees | 1,956 | 1,839 |
Accrued professional services and associated costs | 4,456 | 2,307 |
Accrued employee stock purchase plan withholdings liability | 1,449 | 1,958 |
Other current liabilities | 8,120 | 9,271 |
Total accounts payable, accrued expenses and other current liabilities | $ 33,740 | $ 38,766 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 12,333 | $ 11,565 | $ 24,398 | $ 22,577 |
Cost of revenue | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 698 | 768 | 1,386 | 1,412 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 3,155 | 4,067 | 5,906 | 7,886 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 2,607 | 2,768 | 5,390 | 5,563 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 5,873 | $ 3,962 | $ 11,716 | $ 7,716 |
Stock-Based Compensation - Sc_2
Stock-Based Compensation - Schedule of Stock Options Activity (Details) $ / shares in Units, $ in Thousands | 6 Months Ended | 12 Months Ended |
Jul. 31, 2024 USD ($) $ / shares shares | Jan. 31, 2024 USD ($) $ / shares shares | |
Outstanding Stock Options | ||
Balance, beginning of period (in shares) | shares | 2,021,494 | |
Granted (in shares) | shares | 0 | |
Exercised (in shares) | shares | (258,606) | |
Forfeited or canceled (in shares) | shares | (9,709) | |
Balance, end of period (in shares) | shares | 1,753,179 | 2,021,494 |
Vested and expected to vest (in shares) | shares | 1,753,179 | |
Exercisable at end of period (in shares) | shares | 1,753,179 | |
Weighted-Average Exercise Price | ||
Balance, beginning of period (in dollars per share) | $ / shares | $ 6.26 | |
Granted (in dollars per share) | $ / shares | 0 | |
Exercised (in dollars per share) | $ / shares | 3.06 | |
Forfeited or canceled (in dollars per share) | $ / shares | 10.35 | |
Balance, end of period (in dollars per share) | $ / shares | 6.71 | $ 6.26 |
Vested and expected to vest (in dollars per share) | $ / shares | 6.71 | |
Exercisable at end of period (in dollars per share) | $ / shares | $ 6.71 | |
Balance, Weighted-Average Remaining Contractual Life (in years) | 1 year 9 months 25 days | 2 years 2 months 12 days |
Vested and expected to vest, Weighted-Average Remaining Contractual Life (in years) | 1 year 9 months 25 days | |
Exercisable at end of period, Weighted-Average Remaining Contractual Life (in years) | 1 year 9 months 25 days | |
Balance, Aggregate Intrinsic Value | $ | $ 227 | $ 989 |
Vested and expected to vest, Aggregate Intrinsic Value | $ | 227 | |
Exercisable at end of period, Aggregate Intrinsic Value | $ | $ 227 |
Stock-Based Compensation - Sc_3
Stock-Based Compensation - Schedule of Restricted Stock and Restricted Stock Units (Details) - Restricted stock and restricted stock units | 6 Months Ended |
Jul. 31, 2024 $ / shares shares | |
Outstanding | |
Balance, beginning of period (in shares) | shares | 9,790,748 |
Granted (in shares) | shares | 4,650,552 |
Vested and converted to shares (in shares) | shares | (2,183,455) |
Forfeited or canceled (in shares) | shares | (1,424,528) |
Balance, end of period (in shares) | shares | 10,833,317 |
Weighted-Average Grant Date Fair Value | |
Beginning of period (in dollars per share) | $ / shares | $ 7.54 |
Granted (in dollars per share) | $ / shares | 5.58 |
Vested and converted to shares (in dollars per share) | $ / shares | 8.96 |
Forfeited or canceled (in dollars per share) | $ / shares | 7.12 |
Balance, end of period (in dollars per share) | $ / shares | $ 6.47 |
Stock-Based Compensation - Sc_4
Stock-Based Compensation - Schedule of Performance-Based Restricted Stock Units (Details) - Performance-based restricted stock units | 6 Months Ended |
Jul. 31, 2024 $ / shares shares | |
Number of PSUs | |
Balance, beginning of period (in shares) | shares | 3,555,000 |
Granted (in shares) | shares | 0 |
Vested (in shares) | shares | 0 |
Forfeited or canceled (in shares) | shares | (25,000) |
Balance, end of period (in shares) | shares | 3,530,000 |
Weighted-Average Grant Date Fair Value | |
Beginning of period (in dollars per share) | $ / shares | $ 5.98 |
Granted (in dollars per share) | $ / shares | 0 |
Vested (in dollars per share) | $ / shares | 0 |
Forfeited or canceled (in dollars per share) | $ / shares | 5.05 |
Balance, end of period (in dollars per share) | $ / shares | $ 5.98 |
Debt (Details)
Debt (Details) - USD ($) $ in Millions | Jul. 26, 2024 | Jul. 31, 2024 |
Secured Debt | Revolving Credit Line | ||
Line of Credit Facility [Line Items] | ||
Borrowing capacity | $ 50 | $ 50 |
Incremental borrowing available under certain conditions | $ 50 | |
Line of credit facility, unused capacity, commitment fee percentage | 0.25% | |
Capital stock of foreign subsidiary (as a percent) | 66% | |
Debt instrument minimum liquidity amount | $ 35 | |
Debt instrument maximum consolidated leverage ratio | 300% | |
Line of credit facility, available borrowing capacity | 36.6 | |
Secured Debt | Revolving Credit Line | Secured Overnight Financing Rate (SOFR) | ||
Line of Credit Facility [Line Items] | ||
Basis spread floor (as a percent) | 1% | |
Secured Debt | Revolving Credit Line | Secured Overnight Financing Rate (SOFR) | Minimum | ||
Line of Credit Facility [Line Items] | ||
Basis spread on variable rate (as a percent) | 1.75% | |
Secured Debt | Revolving Credit Line | Secured Overnight Financing Rate (SOFR) | Maximum | ||
Line of Credit Facility [Line Items] | ||
Basis spread on variable rate (as a percent) | 2.25% | |
Secured Debt | Revolving Credit Line | Base Rate | Minimum | ||
Line of Credit Facility [Line Items] | ||
Basis spread on variable rate (as a percent) | 1.25% | |
Secured Debt | Revolving Credit Line | Base Rate | Maximum | ||
Line of Credit Facility [Line Items] | ||
Basis spread on variable rate (as a percent) | 0.75% | |
Line of Credit | Letter of Credit | ||
Line of Credit Facility [Line Items] | ||
Borrowing capacity | $ 30 | |
Debt instrument, collateral amount | $ 13.4 | |
Line of Credit | Bridge Loan | ||
Line of Credit Facility [Line Items] | ||
Borrowing capacity | $ 10 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||||
Benefit from (provision for) income taxes | $ 1,442 | $ (661) | $ 1,221 | $ (982) |
Commitments and Contingencies -
Commitments and Contingencies - Schedule of Future Minimum Contractual Obligation Payments (Details) $ in Thousands | Jul. 31, 2024 USD ($) |
Leases | |
2025 (remainder of fiscal year) | $ 8,562 |
2026 | 19,274 |
2027 | 19,340 |
2028 | 19,437 |
2029 | 19,297 |
2030 and thereafter | 36,473 |
Total | 122,383 |
Other | |
2025 (remainder of fiscal year) | 21,342 |
2026 | 15,675 |
2027 | 8,937 |
2028 | 4,525 |
2029 | 16 |
2030 and thereafter | 94 |
Total | $ 50,589 |
Net Loss Per Share Attributab_3
Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jul. 31, 2024 | Jul. 31, 2023 | Jul. 31, 2024 | Jul. 31, 2023 | |
Numerator: | ||||
Net loss attributable to common stockholders | $ (4,057) | $ (3,437) | $ (7,874) | $ (3,849) |
Denominator: | ||||
Weighted-average common shares outstanding, basic (in shares) | 126,535,481 | 124,358,526 | 125,967,631 | 123,821,653 |
Weighted-average common shares outstanding, diluted (in shares) | 126,535,481 | 124,358,526 | 125,967,631 | 123,821,653 |
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.06) | $ (0.03) |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.06) | $ (0.03) |
Net Loss Per Share Attributab_4
Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares | 6 Months Ended | |
Jul. 31, 2024 | Jul. 31, 2023 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 16,489,920 | 16,753,327 |
Restricted stock and restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 10,833,317 | 11,167,766 |
Shares estimated to be purchased under ESPP | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 373,424 | 225,903 |
Performance-based restricted stock units | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 3,530,000 | 2,280,000 |
Additional Shares Based on TSR | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 1,300,000 | |
Common Stock | Options to purchase common stock | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total anti-dilutive common equivalent shares (in shares) | 1,753,179 | 3,079,658 |
Subsequent Events (Details)
Subsequent Events (Details) - Hearsay - Subsequent Event $ in Millions | Aug. 01, 2024 USD ($) |
Subsequent Event [Line Items] | |
Purchase price | $ 125 |
Participation Rights | |
Subsequent Event [Line Items] | |
Contingent consideration | $ 20 |
Participation rights vesting percentage | 100% |
Earnout Consideration | |
Subsequent Event [Line Items] | |
Contingent consideration | $ 75 |